DAWN TUTONE: Open Payments
NPI 1790233872 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 23 payments from 7 companies in 2025. Trend: 2023 $471 · 2024 $683 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $179 |
| Novo Nordisk Inc | 8 | $160 |
| Lilly USA, LLC | 2 | $48 |
| Abbott Laboratories | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
Products named: QULIPTA, Wegovy, Ozempic, MOUNJARO, UBRELVY, FREESTYLE LIBRE 3, Kerendia, AIRSUPRA.
Industry payments across VA — which companies pay providers there.
